Evolution of new physical traits in mollusks has declined and grown more predictable over time
Peer-Reviewed Publication
Updates every hour. Last Updated: 19-Jun-2026 12:15 ET (19-Jun-2026 16:15 GMT/UTC)
Think of the brain as a city with traffic lights that keep signals flowing smoothly. In a new study, researchers followed a clue about nitric oxide, a common chemical messenger, and found that, in some forms of autism, if it increases, it may act less like a helpful signal and more like a “stuck button.” When nitric oxide sets off this chain reaction, a key safeguard protein called TSC2 gets lost, and a major control system in cells, mTOR, which helps manage growth and protein-making, can surge into abnormal overdrive. The encouraging twist: when the researchers interrupted that specific step, the system calmed down, pointing to a more concrete “where to look” in the biology of autism and a possible direction for future therapies.
Mitochondrial transplantation is an emerging technique aimed at restoring cellular energy production in diseases marked by mitochondrial dysfunction. However, how transplanted mitochondria interact with recipient cells has remained unclear. In a recent study, researchers from Japan investigated how isolated mitochondria are taken up by cells and proved they remain functional after uptake. Their findings help lay the groundwork for future mitochondrial therapies in regenerative medicine.
Researchers from the Institute of Physics and the Institute of Molecular and Cell Biology of the University of Tartu have shown in a recently published study that antibacterial coatings which initially appear highly effective at destroying bacteria, may lose their performance over time. Therefore, long-term testing is essential for developing the best antibacterial materials.
In a comprehensive review published in Research, investigators from Zhongda Hospital, School of Medicine, Southeast University propose an integrative framework centered on EG to explain this shift from defense to dysfunction. The authors synthesize evidence across single-cell multi-omics, bone-marrow niche remodeling, and immunometabolic reprogramming. By integrating single-cell biology with bedside indicators, this work clarifies why a protective program becomes maladaptive and outlines practical avenues for biomarker-guided stratification.